Sale
Brand:
General
Ta Lenvatinib (30 Tablet / Pack)
Lenvatinib is a targeted therapy that inhibits kinases to halt cancer cell growth and blood vessel formation.
PKR 17500.00
PKR 16625.00
You save: PKR 875.00
Ta Lenvatinib is a targeted cancer therapy known as a kinase inhibitor. It stops cancer cells from growing and prevents the growth of new blood vessels in tumors.
Purpose
It is indicated for the treatment of progressive thyroid and renal cancer.
Ingredients
Lenvatinib
Warnings
1. Monitor blood pressure weekly. 2. Risk of bleeding. 3. Check for liver damage. 4. Avoid in pregnancy.
Side Effects
1. Hypertension. 2. Fatigue. 3. Diarrhea. 4. Weight loss.
Storage Instructions
Store at room temperature (15-30°C).
| Brand | General |
| Status | Active |
Loading reviews...